SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,510,000 | -85.2% | 226,679 | -62.8% | 0.07% | -77.5% |
| Q4 2019 | $43,945,000 | +7993.0% | 608,741 | +15613.5% | 0.32% | +8025.0% |
| Q3 2019 | $543,000 | -98.9% | 3,874 | -98.5% | 0.00% | -98.9% |
| Q2 2019 | $47,736,000 | +15.9% | 260,725 | +0.7% | 0.36% | +22.9% |
| Q1 2019 | $41,174,000 | +957.6% | 258,877 | +372.6% | 0.29% | +910.3% |
| Q1 2017 | $3,893,000 | -3.0% | 54,781 | -30.3% | 0.03% | -6.5% |
| Q4 2016 | $4,015,000 | -61.9% | 78,641 | -65.7% | 0.03% | -63.1% |
| Q3 2016 | $10,543,000 | – | 228,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |